Medicare Panel Laments Holes In Ventricular Assist Device Evidence Base

CMS does not currently have a national coverage determination process open on ventricular assist devices for heart failure, though the agency may open a new one, an agency official said.

A Medicare advisory panel has concluded that while ventricular assist devices can play a key role in managing end-stage heart failure, there are still considerable holes in the evidence base, particularly for patients who have less advanced disease.

CMS convened the Medicare Evidence Development and Coverage Advisory Committee at its Baltimore headquarters on Nov. 14 to gather independent...

Welcome to Medtech Insight

Create an account to read this article

More from Policy & Regulation

More from Medtech Insight

Award-Winning Lioness Implant Addresses ‘Silent Emergency’ Of Preterm Birth

 
• By 

The Lioness non-surgical silicon ring implant is designed to put an end to pre-term births, sparing maternal anguish and saving health system costs. PregnanTech won the Biomed Israel 2025 medtech start-up award, and Limor Sandach told In Vivo how a non-digital technology beat off stiff competition.

Boston Scientific Raises Outlook … Again: Headwinds Offset By EP And Watchman

 

Agent drug coated balloon, Watchman product sales, and electrophysiology (EP) business unit growth offset Acurate discontinuation and tariff headwinds. CEO Michael Mahoney shouted out coronary therapies business and answered questions on CMS proposed Ambulatory Surgical Center codes.

FDA ‘Regulatory Accelerator’ Aims To Speed Digital Health Development

 
• By 

The US FDA has launched the Regulatory Accelerator to expedite digital health product development. This includes resources like a Resource Index for Innovators, a Medical Device Software Guidance Navigator, and best practices for early meetings.